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Introduction
Mitosis is a complex process that allows the mother cell to di-
vide into two daughter cells. During this event, equal segrega-
tion of genetic information is crucial. Indeed, any perturbation 
during chromosome segregation could lead to aneuploidy, a 
major cause of cancer (Ganem et al., 2009). The centrosome plays 
a major role in the cell cycle by serving as a signaling platform 
and by nucleating mitotic spindle microtubules. The centrosome 
cycle is regulated concomitantly with cell cycle progression and 
is controlled by several factors including the mitotic kinase 
Aurora A (AurA). AurA is a serine/threonine kinase that fulfills 
several key functions during the cell cycle. AurA is involved in 
G2/M transition, centrosome separation and maturation, mitotic 
spindle assembly, and in the G2/M and spindle assembly check-
points. To fulfill these functions, AurA needs to be correctly lo-
cated and activated at the appropriate time. Several AurA activators 
have been reported in the past decade, although the data are con-
troversial. Indeed, the first reported AurA activators, Bora and 
Ajuba, have never been confirmed. Bora is rather an intermedi-
ate that stimulates PLK1 phosphorylation by AurA (Seki et al., 
2008), and Ajuba has been demonstrated to not activate AurA in 
Drosophila melanogaster (Sabino et al., 2011). TPX2 (Eyers 
et al., 2003; Dodson and Bayliss, 2012), HEF1 (Pugacheva and 
Golemis, 2005), and, more recently, CEP192 (Joukov et al., 
2010) and Arpc1b (Molli et al., 2010) have also been described 
as AurA activators. All these studies showed an increase in AurA 
phosphorylation on threonine 288 (T288), concomitant with ac-
tivation of the kinase. T288 is located in the activation loop of 
the kinase and is directly involved in the activity of AurA. The 
fact that AurA is activated sequentially by several molecules 
suggests a fine tuning of the control of AurA activity and a com-
plex regulatory network in which each activator increases the 
kinase activity for a specific function. It also opens new avenues 
to discover more activating proteins.
Nucleophosmin/B23 (NPM) is a phosphoprotein localized 
mainly in the nucleolus, where it exerts several of its functions. 
NPM also localizes to centrosomes, and a proportion of the pro-
tein continuously shuttles between the nucleus and the cytoplasm. 
NPM is involved in ribosome biogenesis, centrosome duplica-
tion, DNA repair, and response to stress. More recently, NPM was 
shown to be involved in mitotic spindle formation and regulation 
of microtubule spindle tension (Amin et al., 2008a,b). NPM has 
Aurora A (AurA) is a major mitotic protein kinase involved in centrosome maturation and spindle assembly. Nucleophosmin/B23 (NPM) is a pleio-
tropic nucleolar protein involved in a variety of cellular 
processes including centrosome maturation. In the present 
study, we report that NPM is a strong activator of AurA 
kinase activity. NPM and AurA coimmunoprecipitate and 
colocalize to centrosomes in G2 phase, where AurA be-
comes active. In contrast with previously characterized AurA 
activators, NPM does not trigger autophosphorylation of 
AurA on threonine 288. NPM induces phosphorylation of 
AurA on serine 89, and this phosphorylation is necessary 
for activation of AurA. These data were confirmed in vivo, 
as depletion of NPM by ribonucleic acid interference 
eliminated phosphorylation of CDC25B on S353 at the 
centrosome, indicating a local loss of AurA activity. Our 
data demonstrate that NPM is a strong activator of AurA 
kinase activity at the centrosome and support a novel 
mechanism of activation for AurA.
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TPX2 activates AurA through conformational changes and trig-
gers protection of the T288 residue from dephosphorylation by 
PP1 phosphatase (Bayliss et al., 2003; Dodson and Bayliss, 2012). 
To confirm that NPM does not act like TPX2, we tested whether 
preincubation of AurA with increasing amounts of TPX2, or NPM, 
protected T288 phosphorylation. As previously reported, TPX2 
protected AurA from dephosphorylation by PP1 (Fig. 2 A; Eyers 
et al., 2003). We repeated the experiment with NPM. Addition 
of increasing amounts of NPM to AurA did not protect T288 
from being dephosphorylated by PP1 (Fig. 2 B). This finding 
indicates that NPM acts as an AurA kinase activator but, unlike 
TPX2, does not protect the T288 residue from being dephos-
phorylated. Even if T288 phosphorylation was not modified 
when AurA was activated by NPM, this phosphorylation event 
remained necessary for kinase activation. Indeed, NPM was not 
able to trigger AurA activation when T287/288 was mutated 
into alanine, a nonphosphorylable residue (Fig. S1). Any AurA 
protein detected by the anti–phospho-T288 antibody is usually 
considered as active, and this labeling is often used to measure 
been implicated in the pathogenesis of several human malig-
nancies and described both as an oncogene and a tumor sup-
pressor, depending on the cell type and protein levels.
In the present study, we found that NPM is a strong acti-
vator of AurA in vitro. Our data show that NPM activates AurA 
through a novel mechanism that does not depend on T288 phos-
phorylation. Importantly, we showed that activation strongly de-
pends on autophosphorylation of AurA on serine 89 (S89). We 
found that in vivo, AurA and NPM colocalize at the centrosome 
and coimmunoprecipitate. Activation of AurA by NPM was 
validated at the cellular level, as depletion of NPM by RNAi 
leads to a decrease in S353 phosphorylation in CDC25B, a target 
of AurA at the centrosome.
Results and discussion
We initially identified NPM in a screen designed to search for 
AurA substrates in mammalian cell extracts. We evaluated the 
activity of AurA in an in vitro kinase assay using GST-tagged 
H3 tail as a substrate (Scrittori et al., 2001). Purified histidine-
tagged AurA was an active kinase, as it phosphorylated H3 
(Fig. 1 A). We also confirmed that AurA phosphorylated GST-
tagged NPM in vitro (Fig. 1 B, top). Moreover, we detected AurA 
autophosphorylation (Fig. 1, A and B). Surprisingly, AurA showed 
a stronger kinase activity against NPM than H3. An AurA con-
centration as low as 0.5 pmol was sufficient to phosphorylate 
NPM, whereas we did not detect any phosphorylation of H3 at 
that concentration of kinase (unpublished data). We only observed 
phosphorylation of H3 when the kinase concentration was in-
creased up to 20 pmol (Fig. 1 A). AurA activity is commonly 
associated with phosphorylation of T288 on AurA (Bischoff 
et al., 1998). Intriguingly, we did not detect any increase in AurA 
T288 phosphorylation, as revealed by Western blotting using 
specific anti–phospho-T288 AurA antibody (Fig. 1 B, bottom).
Because AurA kinase activity was more intense when NPM 
was used as a substrate compared with H3, we investigated 
whether NPM could act as an activator of AurA kinase activity. 
We performed enzymatic assays with a limiting amount of kinase 
(0.5 pmol; Fig. 1 C). In the absence of NPM, autophosphoryla-
tion of AurA was not detectable, and phosphorylation of H3 was 
hardly detected (Fig. 1 C, first lane). The amount of AurA and 
H3 was kept unchanged, and we gradually increased the amount 
of NPM. As shown in Fig. 1 C (top, third to sixth lane), addition 
of increasing amounts of NPM resulted in increased phosphory-
lation of NPM as well as H3 and AurA. This clearly indicated that 
stimulation of AurA kinase activity correlated with the amount 
of NPM protein. Phosphorylation of H3 reached a plateau when 
the proportion of 5 pmol of NPM for 0.5 pmol of AurA was 
reached. During the past decade, several AurA activators were 
identified (Eyers et al., 2003; Pugacheva and Golemis, 2005; 
Hutterer et al., 2006; Joukov et al., 2010; Molli et al., 2010). 
However, mechanisms of activation have only been documented 
for TPX2 and CEP192. In both cases, activation was associated 
with a strong phosphorylation of AurA on T288. We observed no 
significant increase in T288 phosphorylation in AurA, as detected 
with an anti–phospho-T288 AurA antibody (Fig. 1 C), suggesting 
that NPM could activate AurA through an alternative mechanism. 
Figure 1. AurA phosphorylates H3 and NPM in vitro. (A) 20 pmol of 
AurA was incubated for 10 min at 37°C with 10 pmol of H3. H3 phos-
phorylation (*) was assessed by autoradiography (top), and the presence 
of AurA and H3 proteins was verified by Coomassie blue staining (bottom). 
(B) 0.5 pmol of AurA was incubated for 10 min at 37°C with 10 pmol of 
NPM. NPM phosphorylation was assessed by autoradiography (top), and 
the presence of NPM protein was assessed by Coomassie blue staining 
(middle). Autophosphorylation of AurA on T288 was verified by Western 
blotting (bottom). (C) 0.5 pmol of AurA was incubated with 10 pmol of H3 
and the indicated amount of NPM. NPM, AurA, and H3 phosphorylation 
were assessed by autoradiography (top). NPM, H3, AurA, and AurA auto-
phosphorylations on T288 (pT288) were evaluated by Western blotting or 
Coomassie blue staining. Molecular mass is indicated in kilodaltons.
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AurA activity (Saskova et al., 2008; Tong et al., 2008). How-
ever, three studies suggest that T288 phosphorylation is not an 
absolute readout to evaluate AurA activity. First, phosphatase 
inhibitor-2 can directly activate AurA without modifying T288 
phosphorylation level (Satinover et al., 2004). Second, we showed 
that activity of Xenopus laevis AurA kinase phosphorylated on 
T295 (equivalent of T288 in human) could be down-regulated dur-
ing oocyte maturation upon phosphorylation on S349 (Pascreau 
et al., 2008). Third, Dodson and Bayliss (2012) recently showed 
that binding of TPX2 without phosphorylation on T288 was 
sufficient to activate the kinase.
Fig. 1 C shows that AurA activation is accompanied by an 
increase in AurA autophosphorylation. However, Figs. 1 C and 
2 B show that T288 is not increasingly phosphorylated in the 
presence of NPM. These results prompted us to think that phos-
phorylation of another residue could be involved in the activa-
tion. We used phosphoproteomics analysis to determine which 
residues were phosphorylated in AurA. We found that S89 was 
the only new residue on AurA to be phosphorylated in the pres-
ence of NPM (a result obtained from two independent pro-
teomic facilities). S89 is located in the N terminus extension of 
AurA and has never previously been reported to be phosphory-
lated. This part of the kinase likely participates in localization 
and regulation of the activity of AurA (Rannou et al., 2008). This 
residue is well conserved among vertebrates. To assess whether 
S89 phosphorylation could play a role in AurA activation by 
NPM, we performed in vitro kinase assays with recombinant 
AurA proteins in which the residue S89 was mutated into an 
alanine (S89A, which cannot be phosphorylated) and into aspar-
tic or glutamic acid (S89D or S89E, respectively, which should 
mimic a constitutive phosphorylation). We then compared the 
activity of the AurA S89 mutants with the wild-type (WT) kinase 
by monitoring H3 phosphorylation in the presence of increasing 
amounts of NPM. Fig. 2 C shows that S89A mutant was not ac-
tivated by NPM anymore, thus indicating that S89 phosphoryla-
tion was necessary for activation of AurA by NPM. S89D or 
S89E mutants possess a basal activity similar to WT AurA and 
were not activated by NPM as S89A mutant. The fact that these 
mutants did not behave like phosphomimetic mutants was not 
surprising, and it is now well accepted that glutamic acid or aspar-
tic acid does not systematically mimic phosphorylation (Eyers 
and Maller, 2004; Pascreau et al., 2008; Anthis et al., 2009). It 
is likely that, similar to the results obtained by Paleologou et al. 
(2008), mutation of S89 into glutamic or aspartic acid does not 
exactly modify AurA conformation as phosphorylation of S89 
does. We then searched for the NPM domain responsible for 
AurA activation. We used four constructs to produce various 
truncated NPM proteins (Fig. 2 D). Fig. 2 E shows that the do-
main that allowed activation of AurA was in the C terminus of 
NPM in the P3 fragment. To date, no specific function has been 
attributed to this NPM domain.
To determine the in vivo relevance of the NPM and AurA 
interaction, we investigated whether the two proteins could 
colocalize in vivo. NPM is a nucleolar protein, also reported to 
localize to centrosomes (Zatsepina et al., 1995), between cen-
trioles (Okuda et al., 2000). Similarly, AurA localizes to centro-
somes from the end of S phase to the beginning of G1 phase 
Figure 2. NPM activates AurA through S89 phosphorylation without pro-
tecting T288 from dephosphorylation. (A and B) 0.5 pmol of AurA was 
incubated with the indicated amount of TPX2 or NPM and then treated 
with 0.05 U of PP1. AurA, NPM protein, and AurA autophosphorylation 
on T288 (pT288) were evaluated by Western blotting. (C) 0.5 pmol of WT 
AurA or the indicated mutant was incubated with 10 pmol of H3 and the 
indicated amount of NPM. H3 phosphorylation (*) was quantified by auto-
radiography. (D) A scheme representing the different fragments of NPM 
used in E. NES, nuclear export signal. (E) 0.5 pmol of AurA was incubated 
with 10 pmol of H3 and the indicated amounts of the fragments of NPM 
presented in D. H3 phosphorylation was evaluated by autoradiography. 
Molecular mass is indicated in kilodaltons.
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CDC25B phosphorylation. CDC25B is phosphorylated on serine 
353 by AurA at the end of G2 just before G2/M transition. This 
phosphorylation event can be monitored using the phospho-
specific SE96 antibody (Dutertre et al., 2004; Cazales et al., 2005; 
Krystyniak et al., 2006). Under these conditions, we analyzed the 
phosphorylation status of CDC25B on S353 using Western blot-
ting. We detected a strong decrease in phosphorylation of S353 
in CDC25B when NPM was depleted, though the protein levels 
of CDC25B and AurA were unchanged (Fig. 4 A). We obtained 
the same results by using two other ShRNAs targeting different 
sequences (Fig. S3). In contrast to NPM depletion, NPM over-
expression (with NPM tagged at the N or C terminus end) did 
not change the phosphorylation of S353 in CDC25B, suggesting 
that under physiological conditions, AurA is likely to be fully 
activated by NPM (unpublished data). We further asked in vitro 
whether NPM was able to activate phosphorylation of CDC25B 
by AurA, similar to what we observed concerning H3. Fig. 4 B 
confirmed that addition of increasing amounts of NPM activated 
the kinase and increased phosphorylation of CDC25B. To verify 
that lack of S353 phosphorylation of CDC25B in the absence of 
NPM was occurring at the centrosome, we used the same anti–
phospho-CDC25B antibody to evaluate the phosphorylation of 
S353 in proliferating cells by IF. Late G2 cells were distributed 
according to the intensity of centrosomal labeling. In control cells, 
10% of cells showed no labeling, 45% showed weak labeling, 
and 45% of cells showed strong labeling (Fig. 4 C). When NPM 
was depleted, 35% of cells showed no labeling, 50% showed weak 
labeling, and only 15% of cells showed strong labeling (Fig. 4 D). 
These results clearly indicated a decrease in CDC25B phosphory-
lation on S353 in the absence of NPM, demonstrating that AurA 
kinase was less active at the centrosome in the absence of NPM. 
They also indicated that activation of AurA by NPM was quite 
specific toward CDC25B, as PLK1 phosphorylation was not 
affected by NPM depletion. This last result could also be explained 
by the fact that phosphorylation of PLK1 by AurA is already 
stimulated by Bora (Macůrek et al., 2008; Seki et al., 2008). Im-
portantly, similar to our in vitro findings, phosphorylation of AurA 
on T288 was not dependent on the presence of NPM (Fig. 4 E).
We then wanted to confirm in vivo that AurA activation 
by NPM acts through phosphorylation of S89 on AurA. Because 
of lack of S89 phospho-specific antibody, we could not directly 
evaluate the phosphorylation state of S89 in the presence or ab-
sence of NPM. To study the effect of S89 phosphorylation on 
AurA activity in vivo, we examined the effect of expression of 
S89 mutant versions of AurA on CDC25B phospho-S353 label-
ing at the centrosome. Cells were first transfected with plasmids 
encoding for WT, S89A, S89D, or S89E GFP-tagged AurA pro-
teins, resulting in physiological level of expression of the WT 
or mutated kinases. Endogenous AurA was depleted by trans-
fection with an siRNA that does not target the transfected 
versions of the kinase. Fig. 5 A indicates that, similar to NPM 
depletion, AurA depletion triggered an increase in the number 
of cells with centrosomes that showed no CDC25B phospho-
S353 labeling and a decrease in the number of cells presenting 
a strong CDC25B phospho-S353 labeling. This phenotype was 
rescued by WT AurA but not by S89A AurA, thus suggesting 
that phosphorylation of AurA on S89 is necessary for the kinase 
(Gopalan et al., 1997; Roghi et al., 1998). We examined the lo-
calization of both proteins by confocal microscopy using a rabbit 
polyclonal anti-NPM antibody and a mouse monoclonal anti-
AurA antibody. As expected, both proteins were found at the 
centrosome at the end of interphase as well as in mitosis (Fig. 3, 
A and B). To study the in vivo physical interaction of NPM and 
AurA, we immunoprecipitated each protein individually from 
HeLa cells and used Western blotting to detect the presence of 
the other protein in the immunoprecipitate. Immunoprecipitations 
were performed with nonsynchronized cells as well as with cells 
synchronized in mitosis. We obtained the same result in both 
cases: NPM was detected in AurA immunoprecipitate, and AurA 
was detected in NPM immunoprecipitate (Fig. 3 C). Therefore, 
both proteins not only colocalize but also interact in vivo.
To investigate whether NPM has any effect on AurA in vivo, 
we examined the phosphorylation of two well-characterized 
substrates of AurA at the centrosome. First, we monitored PLK1 
phosphorylation. This kinase is phosphorylated by AurA on T210, 
and this event is necessary for mitotic entry (Macůrek et al., 2008; 
Seki et al., 2008). We obtained >80% of NPM depletion by trans-
fecting U2OS cells with a plasmid coding a short hairpin RNA 
(ShRNA; Fig. S2 A). PLK1 expression level and phosphoryla-
tion on T210 were first quantified by Western blotting. Fig. S2 A 
indicates that they were not affected by NPM depletion. The 
lack of modification in PLK1 phosphorylation status was con-
firmed by immunofluorescence (IF), as PLK1 phospho-T210 
centrosomal labeling was not affected in NPM-depleted cells 
(Fig. S2 B). Next, we examined the effect of NPM depletion on 
Figure 3. NPM and AurA colocalize from the end of G2 to M phase and 
interact in vivo. (A and B) IF microscopy of cells in G2 phase (A) or meta-
phase (B). (insets) Enlargements of the centrosome area. Bars, 1 µm. (C) A 
Western blot showing coimmunoprecipitation (IP) of AurA and NPM from 
HeLa cell protein extract. Molecular mass is indicated in kilodaltons.
 o
n
 M
arch 27, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published March 26, 2012
 of 8Activation of Aurora A by nucleophosmin • Reboutier et al.
of AurA on S89 is involved in microtubule nucleation and that 
NPM likely participates in nucleation through activation of 
AurA. It is particularly interesting to notice that CDC25B, like 
NPM, is also involved in centrosome duplication (Boutros et al., 
2007) and mitotic spindle formation through microtubule nucle-
ation (Gabrielli et al., 1996). Thus, our study suggests a connection 
between two independent pathways implicating (a) cyclin E/Cdk2, 
NPM, or ROCK II and (b) AurA, CDC25B, or Centrin 2 and 
could open up new perspectives concerning centrosome dupli-
cation and maturation studies.
Materials and methods
DNA constructs and protein purification
pGEX-B23 was provided by K. Fukasawa. pGEX-4T3-NPM-P1, -P2, -P3, 
and -P4 were gifts from I. Hoffmann (German Cancer Research Center, 
Heidelberg, Germany). pMAL-C2-CDC25B3 was a gift from B. Ducommun 
(Institut des Technologies Avancées en sciences du Vivant, Toulouse, France). 
AurA and H3 tail cDNA were cloned in pET29 and pGEX vectors, respec-
tively. AurA mutants (S89A, S89D, S89E, and T287/288A) were generated 
with the QuikChange mutagenesis kit (Agilent Technologies). AurA deple-
tion in U2OS cells was achieved as described in Dutertre et al. (2004). 
NPM depletion in U2OS cells was achieved after transfection with pLKO 
plasmids (available from GenBank/EMBL/DDBJ under accession no. 
NM_002520; Sigma-Aldrich) targeting the following sequences: no. 1, 
to be activated by NPM. In agreement with our previous bio-
chemical data showing that S89D and S89E mutations were 
not phosphomimetic, S89D and S89E mutants could not rescue 
AurA depletion.
AurA plays many crucial roles in cell cycle regulation and 
mitosis achievement. Notably, AurA was proven to be involved 
in microtubule growth through recruitment of microtubule-
nucleating factors at the centrosomes (Joukov, 2011). NPM 
also plays key roles in centrosome biology. It has recently been 
shown to be involved in mitotic spindle formation and regula-
tion of spindle microtubule nucleation and tension (Amin et al., 
2008a,b). NPM involvement in microtubule dynamics could act 
through its interaction with AurA. To test this hypothesis, we 
examined the effect of NPM or AurA depletion on microtubule 
nucleation. Cells were treated by 33 µM nocodazole for 3 h to 
depolymerize microtubules and were then washed four times with 
prewarmed fresh medium. 2 min after washes, cells were fixed 
and labeled for - and -tubulin, and then microtubules nucleat-
ing from centrosomes in G2-phase cells were measured. Fig. 5 B 
showed that microtubules were shorter in cells depleted for NPM 
or AurA than in control. WT AurA was able to rescue this pheno-
type, contrary to S89A AurA. This suggested that phosphorylation 
Figure 4. NPM depletion triggers a decrease in CDC25B phosphorylation. (A) Protein lysates prepared from control or NPM-depleted U2OS cells were 
immunoblotted with the indicated antibodies. (B) 0.5 pmol of AurA was incubated with 10 pmol of CDC25B and the indicated amount of NPM. CDC25B 
phosphorylation (*) was quantified by autoradiography. (C) IF characterization of CDC25B phospho-S353 labeling in control or NPM-depleted U2OS 
cells. Control or NPM-depleted cells were classified into three categories (no, weak, or strong labeling) according to the intensity of CDC25B phospho-
S353 labeling. (D) A histogram representing the distribution of control or NPM-depleted cells in each category. Values are means of three independent 
experiments. 50 cells were counted for each experiment. Error bars represent SEM. (E) Protein lysates prepared from control or NPM-depleted U2OS 
cells were immunoblotted with anti-NPM, anti-AurA, anti–AurA phospho-T288, and with anti–-tubulin as a loading control. Molecular mass is indicated 
in kilodaltons.
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GST-tagged proteins (human NPM and NPM fragments) was performed 
with glutathione Sepharose 4B (GE Healthcare) in accordance with the 
manufacturer’s instructions. Pellets were lysed and loaded into glutathi-
one Sepharose 4B. MBP-CDC25B3 was produced in JM109 bacteria and 
affinity purified on amylose beads following the manufacturer’s instruc-
tions (New England Biolabs, Inc.). Purified proteins were stored at 80°C 
or in 50% glycerol at 20°C.
Cell lines and transfection
Human HeLa cells were grown in DME with penicillin and streptomycin 
(Invitrogen) and 10% FCS (GE Healthcare). Human U2O2 cells were grown 
in McCoy’s Medium with penicillin and streptomycin (Invitrogen) and 10% 
FCS. Cells were transfected in culture medium using jetPRIME (Polyplus 
Transfection) in accordance with the manufacturer’s instructions. Media 
were changed after 24 h. Mitotic cells were collected by mitotic shake-off 
after incubation in 1 µg/ml taxol for 16 h. For expression of GFP-AurA WT 
or S89 mutant versions, cells were transfected for 24 h with the appropri-
ate plasmid, and endogenous AurA was then depleted by transfection with 
siRNA for 24 h.
IF
Cells were preliminarily plated onto glass coverslips. The cells were then 
washed in cold PBS with calcium, fixed with methanol at 20°C for 5 min 
(3 min for CDC25B phospho-S353 and CDC25B), and then washed three 
times in cold PBS and saturated with 5% PBS-BSA (5% PBS-SVF for CDC25B 
phospho-S353 and CDC25B) for 1 h at room temperature. Antibodies in 
5% PBS-BSA (5% PBS-SVF for CDC25B phospho-S353 and CDC25B) were 
added onto the following cells: rabbit anti–NPM PabN1 (1:100; Shinmura 
et al., 2005); mouse anti–-tubulin (1:500, clone GTU88; Sigma-Aldrich); 
mouse anti-AurA (clone 35C11:20; Cremet et al., 2003); CDC25B and 
CDC25B phospho-S353 (1:100; a gift from B. Ducommun); PLK1 (Invitrogen); 
and PLK1 phospho-T210 (1:1,000; BD). These were left overnight at 4°C 
and then washed three times and incubated in the dark with secondary anti-
bodies (anti–mouse and anti–rabbit Alexa Fluor 488 or 555, 1:1,000; 
Invitrogen) for 1 h at room temperature. After three final washes with PBS, 
coverslips were mounted with Prolong gold (Invitrogen) with 1 µg/ml DAPI 
(Sigma-Aldrich). Cells were examined using a fluorescent microscope 
(DMRXA2; Leica) with a 63× oil immersion objective. Images were processed 
using MetaMorph software (Universal Imaging). Cells were also observed 
with a confocal microscope (SP2; Leica), and images were processed with 
Leica software.
Western blot analysis
Cells were lysed in radioimmunoprecipitation assay buffer containing anti-
protease (Complete; Roche), and lysates were clarified by centrifugation 
(13,000 rpm for 30 min at 4°C). Proteins were assayed by Bradford assay 
(Bio-Rad Laboratories). Equal amounts of protein lysates in Laemmli were 
loaded onto 12.5% SDS-PAGE gel for electrophoresis and transferred onto 
nitrocellulose membranes. Membranes were blocked for 1 h at room tem-
perature with TBST–4% milk (5% BSA for NPM) and then incubated over-
night with the following antibodies: mouse anti–-tubulin (1:2,000); mouse 
anti-NPM (1:2,000; Sigma-Aldrich); mouse anti-AurA (clone 35C1, 1:100; 
Cremet et al., 2003); rabbit anti-CDC25B and CDC25B phospho-S353 
(1:1,000; a gift from B. Ducommun); mouse anti-PLK1 (Invitrogen); and PLK1 
phospho-T210. Secondary antibodies coupled with HRP (Jackson Immuno-
Research Laboratories, Inc.) were incubated for 1 h, and antibody binding 
was detected by ECL (Pico or Dura; Thermo Fisher Scientific).
In vitro kinase assays
Different amounts of recombinant AurA, recombinant nucleophosmin, and re-
combinant H3 or CDC25B—as stated in the figures—were mixed in 50 mM 
Tris-HCl, pH 7.5, 25 mM NaCl, 1 mM DTT, 0.01% Triton X-100, and 10 mM 
MgCl2. Then, 100 µM ATP and 2 µCi -[32P]ATP were added to the reaction 
mixture and incubated at 37°C for 10 min. Reactions were stopped in Laemmli 
buffer, boiled for 5 min, and resolved on a 12.5% SDS-PAGE gel. Gels were 
either stained with Coomassie blue, fixed, dried, and autoradiographied with 
Storm 840 (Molecular Dynamics) or were transferred onto nitrocellulose mem-
brane, autoradiographied for 3 d on X-OMAT films (Kodak), and then blocked 
with PBS–4% milk and subjected to immunoblotting.
Mass spectrometry analysis
AurA was proven to be phosphorylated even when purified from E. coli as 
a recombinant protein (Haydon et al., 2003). To clearly discriminate be-
tween phosphorylation events, 1 µg of recombinant AurA was incubated 
for 20 min at 37°C either alone or in presence of 20 mM ATP or in presence 
of 20 mM ATP and 1 µg NPM. Enzymatic reactions were stopped with 
5-CCGGGCCGACAAAGATTATCACTTTCTCGAGAAAGTGATAATCTT-
TGTCGGCTTT-3; no. 2, 5-CCGGGCAAAGGATGAGTTGCACATTCTC-
GAGAATGTGCAACTCATCCTTTGCTTTTTG-3; and no. 3, 5-CCGGC-
CTAGTTCTGTAGAAGACATTCTCGAGAATGTCTTCTACAGAACTAGG-
TTTTTG-3. Luciferase ShRNA was used as a control. AurA WT and S89 
mutant versions were cloned in a pEGFP-C1 vector with the AurA promoter 
sequence to allow physiological expression level. For recombinant protein 
production, BL21 Escherichia coli were transformed with plasmids, induced 
by 1 mM IPTG for 4 h, pelleted, and frozen at 80°C. Purification of histidine-
tagged proteins (human AurA and histone H3) was performed as previously 
described (Roghi et al., 1998). In brief, bacterial pellets were lysed and 
loaded onto Ni–nitrilotriacetic acid agarose beads (QIAGEN) and washed, 
and proteins were eluted with buffer containing imidazole. Purification of 
Figure 5. AurA S89 phosphorylation is required for CDC25B phos-
phorylation and microtubule nucleation at centrosomes. (A) Expression 
of AurA in U2OS cells transfected with the indicated siRNA and/or plas-
mids was verified by Western blotting (top). Anti–-tubulin serves as a 
loading control. For each corresponding cell population, the intensity of 
centrosomal CDC25B phospho-S353 labeling was evaluated, and cells 
were classified into three categories (no, weak, or strong labeling). Data 
are summarized in the histogram (bottom). Values are means of three 
independent experiments. 50 cells were counted for each experiment. 
Error bars represent SEM. (B) IF microscopy of cells with nucleating micro-
tubules at centrosomes. The length of microtubules is summarized in the 
histogram. Data are representative of three independent experiments. Error 
bars represent SEM.
 o
n
 M
arch 27, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published March 26, 2012
7 of 8Activation of Aurora A by nucleophosmin • Reboutier et al.
is a conserved mechanism for regulating talin-induced integrin activation. 
J. Biol. Chem. 284:36700–36710. http://dx.doi.org/10.1074/jbc.M109 
.061275
Bayliss, R., T. Sardon, I. Vernos, and E. Conti. 2003. Structural basis of Aurora-A 
activation by TPX2 at the mitotic spindle. Mol. Cell. 12:851–862. http://
dx.doi.org/10.1016/S1097-2765(03)00392-7
Bischoff, J.R., L. Anderson, Y. Zhu, K. Mossie, L. Ng, B. Souza, B. Schryver, P. 
Flanagan, F. Clairvoyant, C. Ginther, et al. 1998. A homologue of Drosophila 
aurora kinase is oncogenic and amplified in human colorectal cancers. 
EMBO J. 17:3052–3065. http://dx.doi.org/10.1093/emboj/17.11.3052
Boutros, R., V. Lobjois, and B. Ducommun. 2007. CDC25B involvement in the 
centrosome duplication cycle and in microtubule nucleation. Cancer Res. 
67:11557–11564. http://dx.doi.org/10.1158/0008-5472.CAN-07-2415
Cazales, M., E. Schmitt, E. Montembault, C. Dozier, C. Prigent, and B. Ducommun. 
2005. CDC25B phosphorylation by Aurora-A occurs at the G2/M transi-
tion and is inhibited by DNA damage. Cell Cycle. 4:1233–1238. http://
dx.doi.org/10.4161/cc.4.9.1964
Cremet, J.Y., S. Descamps, F. Vérite, A. Martin, and C. Prigent. 2003. 
Preparation and characterization of a human aurora-A kinase monoclo-
nal antibody. Mol. Cell. Biochem. 243:123–131. http://dx.doi.org/10 
.1023/A:1021608012253
Dodson, C.A., and R. Bayliss. 2012. Activation of Aurora-A kinase by protein 
partner binding and phosphorylation are independent and synergistic. 
J. Biol. Chem. 287:1150–1157. http://dx.doi.org/10.1074/jbc.M111.312090
Dutertre, S., M. Cazales, M. Quaranta, C. Froment, V. Trabut, C. Dozier, G. Mirey, 
J.P. Bouché, N. Theis-Febvre, E. Schmitt, et al. 2004. Phosphorylation of 
CDC25B by Aurora-A at the centrosome contributes to the G2-M transi-
tion. J. Cell Sci. 117:2523–2531. http://dx.doi.org/10.1242/jcs.01108
Eyers, P.A., and J.L. Maller. 2004. Regulation of Xenopus Aurora A activation 
by TPX2. J. Biol. Chem. 279:9008–9015. http://dx.doi.org/10.1074/jbc 
.M312424200
Eyers, P.A., E. Erikson, L.G. Chen, and J.L. Maller. 2003. A novel mechanism 
for activation of the protein kinase Aurora A. Curr. Biol. 13:691–697. 
http://dx.doi.org/10.1016/S0960-9822(03)00166-0
Gabrielli, B.G., C.P. De Souza, I.D. Tonks, J.M. Clark, N.K. Hayward, and K.A. 
Ellem. 1996. Cytoplasmic accumulation of cdc25B phosphatase in mito-
sis triggers centrosomal microtubule nucleation in HeLa cells. J. Cell Sci. 
109:1081–1093.
Ganem, N.J., S.A. Godinho, and D. Pellman. 2009. A mechanism linking extra 
centrosomes to chromosomal instability. Nature. 460:278–282. http://
dx.doi.org/10.1038/nature08136
Gopalan, G., C.S. Chan, and P.J. Donovan. 1997. A novel mammalian, mitotic 
spindle–associated kinase is related to yeast and fly chromosome segrega-
tion regulators. J. Cell Biol. 138:643–656. http://dx.doi.org/10.1083/jcb 
.138.3.643
Haydon, C.E., P.A. Eyers, L.D. Aveline-Wolf, K.A. Resing, J.L. Maller, and 
N.G. Ahn. 2003. Identification of novel phosphorylation sites on Xenopus 
laevis Aurora A and analysis of phosphopeptide enrichment by immobi-
lized metal-affinity chromatography. Mol. Cell. Proteomics. 2:1055–
1067. http://dx.doi.org/10.1074/mcp.M300054-MCP200
Hutterer, A., D. Berdnik, F. Wirtz-Peitz, M. Zigman, A. Schleiffer, and J.A. 
Knoblich. 2006. Mitotic activation of the kinase Aurora-A requires its 
binding partner Bora. Dev. Cell. 11:147–157. http://dx.doi.org/10.1016/ 
j.devcel.2006.06.002
Joukov, V. 2011. Aurora kinases and spindle assembly: Variations on a common 
theme? Cell Cycle. 10:895–903. http://dx.doi.org/10.4161/cc.10.6.14909
Joukov, V., A. De Nicolo, A. Rodriguez, J.C. Walter, and D.M. Livingston. 
2010. Centrosomal protein of 192 kDa (Cep192) promotes centrosome-
driven spindle assembly by engaging in organelle-specific Aurora A acti-
vation. Proc. Natl. Acad. Sci. USA. 107:21022–21027. http://dx.doi.org/ 
10.1073/pnas.1014664107
Krystyniak, A., C. Garcia-Echeverria, C. Prigent, and S. Ferrari. 2006. Inhibition 
of Aurora A in response to DNA damage. Oncogene. 25:338–348.
Macůrek, L., A. Lindqvist, D. Lim, M.A. Lampson, R. Klompmaker, R. Freire, 
C. Clouin, S.S. Taylor, M.B. Yaffe, and R.H. Medema. 2008. Polo-like 
kinase-1 is activated by aurora A to promote checkpoint recovery. Nature. 
455:119–123. http://dx.doi.org/10.1038/nature07185
Molli, P.R., D.Q. Li, R. Bagheri-Yarmand, S.B. Pakala, H. Katayama, S. Sen, J. 
Iyer, J. Chernoff, M.Y. Tsai, S.S. Nair, and R. Kumar. 2010. Arpc1b, a 
centrosomal protein, is both an activator and substrate of Aurora A. J. Cell 
Biol. 190:101–114. http://dx.doi.org/10.1083/jcb.200908050
Okuda, M., H.F. Horn, P. Tarapore, Y. Tokuyama, A.G. Smulian, P.K. Chan, 
E.S. Knudsen, I.A. Hofmann, J.D. Snyder, K.E. Bove, and K. Fukasawa. 
2000. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome 
duplication. Cell. 103:127–140. http://dx.doi.org/10.1016/S0092-8674(00) 
00093-3
Paleologou, K.E., A.W. Schmid, C.C. Rospigliosi, H.Y. Kim, G.R. Lamberto, R.A. 
Fredenburg, P.T. Lansbury Jr., C.O. Fernandez, D. Eliezer, M. Zweckstetter, 
Laemmli buffer. Proteins were separated in SDS-PAGE, and the gel was 
stained with Coomassie blue.
The gel slices were destained with 50% methanol and then reduced 
in 10 mM DTT for 1 h at 56°C and alkylated in 55 mM chloroacetamide for 
1 h at room temperature. After washing in 50 mM ammonium bicarbonate, 
the gel pieces were shrunk in 100% acetonitrile. The digestion was performed 
using trypsin in 50 mM ammonium bicarbonate for 8 h at 37°C and 600 rpm. 
The peptides were finally extracted in 90% acetonitrile/0.5 M Urea and 
dried in SpeedVac (Thermo Fisher Scientific). Samples were resolubilized 
in 5% acetonitrile and 0.2% formic acid. Samples were separated on a 
homemade C18 column (150 µm × 10 cm) using a nanoLC 2D system 
(Eksigent). A 56-min gradient from 5–60% acetonitrile (0.2% formic acid) 
was used to elute peptides from a homemade reversed-phase column 
(150 µm i.d. × 100 mm) with a flow rate set at 600 nanoliters/min.
The column was directly connected to a nanoprobe interfaced with 
a mass spectrometer (LTQ Orbitrap Velos; Thermo Fisher Scientific). Each full 
mass spectrometry spectrum was followed by 12 tandem mass spectrometry 
(MS/MS) spectra (13 scan events), in which the 12 most abundant multiply 
charged ions were selected for MS/MS sequencing. MS/MS experiments 
were performed using collision-induced dissociation in the linear ion trap. The 
data were processed using the Mascot 2.1 search engine (Matrix Science) 
with tolerance parameters set to 15 parts per million and 0.5 D for the pre-
cursor and the fragment ions, respectively. The selected variable modifications 
were carbamidomethyl (C), deamidation (NQ), oxidation (M), and phosphory-
lation (STY). The selected database was Human International Protein Index 
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Immunoprecipitation
Protein G Sepharose Fast Flow (GE Healthcare) and monoclonal anti-AurA 
(Cremet et al., 2003) clone 35C1 or monoclonal anti-B23 (Sigma-Aldrich) 
were incubated overnight at 4°C and then washed extensively. Cells were 
lysed in 20 mM EDTA, 15 mM MgCl2, 20 mM Hepes, pH 7.5, 0.1% Triton 
X-100, antiprotease (Complete), and antiphosphatase cocktail (50 mM 
NaF, 80 mM -glycerophosphate, and 1 mM Na3VO4). Cell lysates were 
loaded onto Protein G Sepharose Fast Flow overnight at 4°C and then sub-
jected to extensive washes in lysis buffer for 4 h at 4°C. Samples were finally 
eluted in Laemmli and boiled for 5 min at 90°C or used in a kinase assay.
Microtubule nucleation assay
Cells were incubated for 3 h with 33 µM nocodazole in culture medium. 
Then, the medium was removed, and cells were washed four times with 
fresh prewarmed medium. 2 min after the last wash, cells were fixed with 
cold methanol and then immunolabeled for - and -tubulin. The length of 
microtubules was measured with MetaMorph software.
Online supplemental material
Fig. S1 indicates that NPM was not able to activate a T287/288A AurA 
mutant. Fig. S2 shows that NPM depletion did not affect phosphoryla-
tion of PLK1. Fig. S3 shows that three different ShRNAs designed to target 
NPM triggered a decrease in CDC25B phosphorylation. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/jcb 
.201107134/DC1.
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